GLUE Insider Holders & Insider Ownership - Monte Rosa Therapeutics Inc.

List of insiders holdings for Monte Rosa Therapeutics Inc.:

Shares directly owned by the insider.
Shares indirectly owned by the insider.
Total shares owned by the insider (sum of shares directly and indirectly owned).
Total market value if available.
Shares are not adjusted for stock split.

"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

#	Insider Holder Name	Report Date Time	Shares Owned Directly Indirectly	Total Shares Owned	Filing
1	New Enterprise Associates 17 L.P. NEA Partners 17 L.P. NEA 17 GP LLC 10% Owner	2024-08-12 19:46:41	7,774,930 0	7,774,930	Form 13D
2	BASKETT FOREST 10% Owner	2021-06-30 18:00:44	0 7,692,298	7,692,298	Form 4
3	Chang Carmen 10% Owner	2021-06-30 18:02:05	0 7,692,298	7,692,298	Form 4
4	Florence Anthony A. Jr. 10% Owner	2021-06-30 18:02:57	0 7,692,298	7,692,298	Form 4
5	Landsman Liza 10% Owner	2021-06-30 18:04:06	0 7,692,298	7,692,298	Form 4
6	Makhzoumi Mohamad 10% Owner	2021-06-30 18:05:03	0 7,692,298	7,692,298	Form 4
7	MAKOWER JOSHUA 10% Owner	2021-06-30 18:06:19	0 7,692,298	7,692,298	Form 4
8	Mathers Edward T 10% Owner	2021-06-30 18:06:59	0 7,692,298	7,692,298	Form 4
9	SANDELL SCOTT D 10% Owner	2021-06-30 18:07:34	0 7,692,298	7,692,298	Form 4
10	Sonsini Peter W. 10% Owner	2021-06-30 18:08:18	0 7,692,298	7,692,298	Form 4
11	Walker Paul Edward 10% Owner	2021-06-30 18:08:50	0 7,692,298	7,692,298	Form 4
12	Yang Rick 10% Owner	2021-06-30 18:09:39	0 7,692,298	7,692,298	Form 4
13	Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner	2024-10-30 17:10:55	4,079,469 0	4,079,469	Form 13D
14	Bolzon Bradley J PhD Director 10% Owner	2021-06-30 17:05:14	0 2,097,938	2,097,938	Form 4
15	Warmuth Markus President & CEO	2025-01-06 16:15:09	1,119,538 0	1,119,538	Form 4
16	Janku Filip Chief Medical Officer	2025-01-06 16:15:12	206,189 0	206,189	Form 4
17	Nickson Philip Chief Business & Legal Officer	2025-01-06 16:15:17	197,000 0	197,000	Form 4
18	Townson Sharon Chief Scientific Officer	2025-01-06 16:15:08	197,000 0	197,000	Form 4
19	Champoux Jennifer Chief Operating Officer	2025-01-06 16:15:11	165,000 0	165,000	Form 4
20	Tamboli Ajim Chief Financial Officer	2023-01-04 16:30:41	129,850 0	129,850	Form 4
21	Wallace Owen B. Chief Scientific Officer	2024-01-04 16:15:41	124,266 0	124,266	Form 4
22	Jones Jullian G Chief Business Officer	2024-01-04 16:15:28	79,000 0	79,000	Form 4
23	Castle John C. Chief Data Scientist	2023-01-04 16:30:57	78,500 0	78,500	Form 4
24	SCHIFF ANDREW N Director	2025-06-16 16:05:03	30,700 0	30,700	Form 4
25	Skvarka Jan Director	2025-06-16 16:05:04	30,700 0	30,700	Form 4
26	Siu Christine Director	2025-06-16 16:05:06	30,700 0	30,700	Form 4
27	Blackwell Kimberly Director	2025-06-16 16:05:08	30,700 0	30,700	Form 4
28	Manning Anthony M. Director	2025-06-16 16:05:10	30,700 0	30,700	Form 4
29	Hughes Eric A Director	2025-06-16 16:05:11	30,700 0	30,700	Form 4
30	Behbahani Ali Director 10% Owner	2025-06-16 16:10:47	30,700 0	30,700	Form 4
31	Dunn Edmund Principal Accounting Officer	2025-06-04 16:15:08	23,732 0	23,732	Form 4
32	Mayweg Alexander Director	2023-06-15 16:27:24	20,500 0	20,500	Form 4
33	Leo Chandra P. Director	2025-03-25 18:32:00	10,000 0	10,000	Form 4
34	Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund III LP Cormorant Private Healthcare Fund II LP Former 10% Owner	2024-02-14 15:02:41	0 0	0	Form 13G

Insider Holders & Insider Ownership - Monte Rosa Therapeutics Inc. (GLUE)